Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca Will Unite Vaccines, Antibody Therapies in New Division
BioSpace
Tue, 11/9/21 - 11:39 pm
Tags:
AstraZeneca, vaccines, antibodies
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
Tags:
GSK, chronic kidney disease, cliincal trials, FDA, AstraZeneca, anemia, erythropoietin, FibroGen
These Clinical Results Are Good News for AstraZeneca
Motley Fool
Sun, 11/7/21 - 10:52 pm
Tags:
AstraZeneca, Imfinizi, biliary tract cancer, clinical trials
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
Tue, 11/2/21 - 11:51 pm
Tags:
HHS, drug pricing, 340B, AstraZeneca, Eli Lilly, Novo Nordisk, Sanofi, United Therapeutics
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
BioSpace
Mon, 11/1/21 - 11:17 pm
Tags:
AstraZeneca, COPD, Covis Pharma, Respiratory
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Tags:
Merck, Keytruda, Xeris Biopharma, XeriJect, Evaxion Biotech, EVX-01, Daiichi Sankyo, AstraZeneca, datopotamab deruxtecan
AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer
Pharmaforum
Mon, 10/25/21 - 11:10 am
Tags:
AstraZeneca, Imfinzi, biliary tract cancer, clinical trials
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
Fierce Biotech
Mon, 10/25/21 - 10:50 am
Tags:
Pharma CEOs, Medivir, AstraZeneca, Jens Lindberg
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test
Fierce Biotech
Wed, 10/20/21 - 06:54 pm
Tags:
AstraZeneca, clinical trials, FDA, clinical hold, AZD5991, AML
Amid Amgen's similar struggles, AstraZeneca slams the brakes on MCL-1 blood cancer drug
Fierce Biotech
Wed, 10/20/21 - 10:20 am
Tags:
AstraZeneca, AZD5991, clinical trials, Amgen, blood cancer
AstraZeneca's former antibiotics unit claims a PhIII win in drug-resistant bacteria affecting sickly patients
Endpoints
Tue, 10/19/21 - 11:05 am
Tags:
AstraZeneca, Entasis Therapeutics, clinical trials, antibiotic resistance
Small biotech says its Covid-19 vaccine spurs more antibodies than AstraZeneca’s. Will supply deals come now?
Endpoints
Mon, 10/18/21 - 11:08 am
Tags:
vaccines, COVID-19, AstraZeneca, VLA2001, Valneva
Biotech innovation lab formed by AstraZeneca, Merck, Pfizer and Teva
Biopharma Reporter
Mon, 10/18/21 - 10:57 am
Tags:
innovation, AION Labs, artificial intelligence, AstraZeneca, Merck, Pfizer, Teva Pharmaceutical
Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?
Motley Fool
Sat, 10/16/21 - 11:27 pm
Tags:
AstraZeneca, COVID-19, FDA
AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer
NASDAQ
Fri, 10/15/21 - 11:03 am
Tags:
AstraZeneca, liver cancer, clinical trials, Imfinzi, tremelimumab
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
Motley Fool
Thu, 10/14/21 - 11:00 am
Tags:
AstraZeneca, breast cancer, clinical trials, Enhertu
Big Pharma companies join hands with Amazon on new Israel-based AI incubator
Endpoints
Wed, 10/13/21 - 11:00 am
Tags:
Merck, Pfizer, AstraZeneca, Teva Pharmaceutical, Amazon, incubators, biotech, artificial intelligence
AstraZeneca's COVID-19 therapy hits goal in phase 3, but efficacy falls short of rivals
Fierce Biotech
Mon, 10/11/21 - 10:15 am
Tags:
AstraZeneca, COVID-19, clinical trials, antibodies
AstraZeneca’s Alexion concludes Caelum acquisition for $500m
Pharmaceutical Business Review
Thu, 10/7/21 - 11:22 am
Tags:
AstraZeneca, Alexion, Caelum Biosciences, M&A
AstraZeneca files for FDA green light of COVID-preventing antibody
Fierce Biotech
Tue, 10/5/21 - 10:36 am
Tags:
AstraZeneca, COVID-19, antibodies, FDA, Emergency Use Authorization

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.